JNJ vs CI
By Alex · Tickerpine
Johnson & Johnson vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CI |
|---|---|---|
| Price | $271.95 | $271.83 |
| Market cap | $655.37B | $71.83B |
| P/E ratio | 31.4 | 11.2 |
| ROE | 25.74% | 16.76% |
| Profit margin | 21.48% | 2.27% |
| Revenue growth | 6.60% | 6.70% |
| Dividend yield | 1.97% | 2.30% |
| Beta | 0.23 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CI in plain English
- JNJ is the bigger company — about 9.1× the market cap of CI.
- CI is cheaper on earnings (P/E 11.2 vs 31.4).
- JNJ earns a higher return on equity (26% vs 17%).
- CI is growing revenue faster (7% vs 7%).
- CI has the higher dividend yield (2.30% vs 1.97%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.